Unknown

Dataset Information

0

Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers.

ABSTRACT:

SUBMITTER: Yu Y 

PROVIDER: S-EPMC8610151 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers.

Yu Yingyan Y  

Cancer biology & medicine 20211001 4

Similar Datasets

Unknown Repurposing drugs for solid tumor treatment: focus on immune checkpoint inhibitors.
| S-EPMC10690875 | biostudies-literature
Unknown Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors.
| S-EPMC10294768 | biostudies-literature
Unknown Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta-analysis.
| S-EPMC8517360 | biostudies-literature
Unknown Update on immune checkpoint inhibitors in gynecological cancers.
| S-EPMC5323287 | biostudies-literature
Unknown Immune checkpoint inhibitors in resectable gastroesophageal cancers - a review.
| S-EPMC9720835 | biostudies-literature
Unknown Current Status of Immune Checkpoint Inhibitors in Gastrointestinal Cancers.
| S-EPMC5479252 | biostudies-literature
Unknown Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology.
| S-EPMC10000896 | biostudies-literature
Unknown Application of Immune Checkpoint Inhibitors in Gynecological Cancers: What Do Gynecologists Need to Know before Using Immune Checkpoint Inhibitors?
| S-EPMC9865129 | biostudies-literature
Unknown Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers.
| S-EPMC11226604 | biostudies-literature
Unknown Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression.
| S-EPMC8971789 | biostudies-literature